Mar 22, 2024
Reevaluating Gabapentin: Addressing the Hidden Risks and Safer Alternatives
Antitrust laws in the generic drug market prevent big pharma from blocking cheaper alternatives through pay-for-delay deals, patent manipulation, and product hopping. These tactics cost consumers billions-but enforcement is evolving.
